Surgepays Short Long Term Debt Total vs Common Stock Shares Outstanding Analysis
SURG Stock | USD 1.75 0.05 2.78% |
Surgepays financial indicator trend analysis is much more than just breaking down Surgepays prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Surgepays is a good investment. Please check the relationship between Surgepays Short Long Term Debt Total and its Common Stock Shares Outstanding accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.
Short Long Term Debt Total vs Common Stock Shares Outstanding
Short Long Term Debt Total vs Common Stock Shares Outstanding Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Surgepays Short Long Term Debt Total account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Surgepays' Short Long Term Debt Total and Common Stock Shares Outstanding is 0.5. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Surgepays, assuming nothing else is changed. The correlation between historical values of Surgepays' Short Long Term Debt Total and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of Surgepays are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Short Long Term Debt Total i.e., Surgepays' Short Long Term Debt Total and Common Stock Shares Outstanding go up and down completely randomly.
Correlation Coefficient | 0.5 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Short Long Term Debt Total
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most indicators from Surgepays' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Surgepays current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.At this time, Surgepays' Enterprise Value Multiple is most likely to increase in the upcoming years. The Surgepays' current Enterprise Value is estimated to increase to about 86.9 M, while Issuance Of Capital Stock is projected to decrease to 516.75.
2023 | 2024 (projected) | Interest Income | 1.3M | 1.1M | Reconciled Depreciation | 1.1M | 740.0K |
Surgepays fundamental ratios Correlations
Click cells to compare fundamentals
Surgepays Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Surgepays fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 10.0M | 7.3M | 19.5M | 34.0M | 41.9M | 44.0M | |
Other Current Liab | 678.0K | 1.9M | 555.1K | 12.9M | 123.2K | 117.1K | |
Total Current Liabilities | 7.1M | 15.3M | 10.0M | 23.5M | 12.7M | 13.3M | |
Total Stockholder Equity | (4.7M) | (10.7M) | 3.6M | 5.0M | 28.2M | 29.7M | |
Net Debt | 8.2M | 7.0M | 1.4M | 1.1M | (9.2M) | (8.7M) | |
Retained Earnings | (10.9M) | (21.6M) | (35.1M) | (35.8M) | (15.2M) | (14.4M) | |
Accounts Payable | 4.6M | 7.3M | 7.4M | 7.5M | 7.3M | 7.7M | |
Cash | 346.0K | 674.0K | 6.3M | 7.0M | 14.6M | 15.4M | |
Cash And Short Term Investments | 346.0K | 674.0K | 6.3M | 7.0M | 14.6M | 15.4M | |
Common Stock Shares Outstanding | 1.9M | 2.1M | 4.4M | 12.4M | 14.9M | 15.7M | |
Liabilities And Stockholders Equity | 10.0M | 7.3M | 19.5M | 34.0M | 41.9M | 44.0M | |
Non Current Liabilities Total | 7.6M | 2.7M | 6.0M | 5.4M | 816.8K | 776.0K | |
Other Current Assets | 1.4M | 172.6B | 5.6K | 111.5K | 161.9K | 153.8K | |
Other Stockholder Equity | 6.1M | 10.7M | 38.7M | 40.8M | 43.4M | 45.6M | |
Total Liab | 14.7M | 18.1M | 15.9M | 28.9M | 13.5M | 7.7M | |
Total Current Assets | 3.6M | 1.3M | 13.9M | 27.6M | 33.4M | 35.0M | |
Common Stock | 102.2K | 127.1K | 12.1K | 14.1K | 14.4K | 15.1K | |
Non Current Assets Total | 6.4M | 6.1M | 5.6M | 6.4M | 8.6M | 9.0M | |
Non Currrent Assets Other | 61.5K | 66.5K | 61.5K | 176.9K | 2.8M | 3.0M | |
Short Long Term Debt Total | 8.5M | 7.7M | 7.7M | 8.1M | 5.4M | 3.8M | |
Property Plant And Equipment Net | 505.4K | 605.4K | 687.1K | 1.1M | 749.7K | 787.2K | |
Net Receivables | 3.1M | 393.1K | 3.2M | 9.2M | 9.5M | 10.0M | |
Short Term Debt | 1.7M | 5.3M | 1.7M | 2.7M | 4.7M | 4.9M | |
Other Assets | (4K) | 66.5K | 61.5K | 176.9K | 203.4K | 213.5K | |
Long Term Debt | 6.6M | 1.7M | 5.5M | 5.0M | 460.5K | 437.5K | |
Inventory | (172.6B) | 178.3K | 4.4M | 11.2M | 9.0M | 9.5M | |
Intangible Assets | 4.8M | 4.1M | 3.4M | 3.2M | 2.7M | 2.0M | |
Property Plant Equipment | 31.0K | 505.4K | 236.8K | 687.1K | 790.2K | 829.7K | |
Net Tangible Assets | (2.9M) | (10.3M) | (15.7M) | (749.2K) | (674.3K) | (708.0K) | |
Short Long Term Debt | 2.1M | 5.9M | 1.7M | 2.7M | 4.6M | 2.5M | |
Other Liab | 883.6K | 600.5K | 869.9K | 852.0K | 979.8K | 808.9K | |
Net Invested Capital | 4.0M | (3.1M) | 10.7M | 12.7M | 33.3M | 35.0M | |
Net Working Capital | (3.5M) | (14.1M) | 3.9M | 4.1M | 20.7M | 21.7M | |
Capital Stock | 115.9K | 140.9K | 12.3K | 14.1K | 14.4K | 13.7K |
Currently Active Assets on Macroaxis
When determining whether Surgepays is a strong investment it is important to analyze Surgepays' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Surgepays' future performance. For an informed investment choice regarding Surgepays Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share (1.18) | Revenue Per Share 6.864 | Quarterly Revenue Growth (0.58) | Return On Assets (0.02) |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.